Skip to content

Synergetic inhibition of deubiquitinases and acetyltransferases to regulate tau acetylation and aggregation in SH-SY5Y cell line model of Alzheimer's disease.

2026 · Methods in Enzymology · Vol 733, pp. 297-319 · 0 citations
Medicine

TL;DR

The development of standardized cell culture models in the SH-SY5Y neuronal system will be crucial to evaluating the therapeutic potential of this synergetic inhibition strategy, thereby restoring ubiquitination and promoting tau degradation.

View source

Similar papers

Review Open access Sep 2026

Breaking the proteasome balance: α-synuclein and the ubiquitin-proteasome system

Aging is the major risk factor for synucleinopathies, including Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. However, the molecular mechanisms linking aging to. α-Synuclein cytotoxicity remain incompletely understood. The progressive decline of proteostasis is central among these mechani...

Tariq T. Ali, B. Popova, G. Braus · 0 citations
Open access Sep 2026

Targeted dephosphorylation of Tau at the endogenous level promotes its association with microtubules

Hyperphosphorylation of Tau is a contributory factor for Tauopathies, which constitute a spectrum of neurodegenerative disorders including Alzheimer’s disease (AD). Inhibitors of Tau kinases or activators of the Tau phosphatase PP2A to reverse Tau hyperphosphorylation have shown limited therapeutic promise, due primari...

Gajanan Sathe, Francesco Berterame, Tyrell Cartwright et al. · 0 citations
Open access Aug 2026

G3BP1 depletion, observed in Parkinson's Disease, drives Golgi-lysosome-autophagy defects.

It is demonstrated that G3BP1 also stabilises the COPI vesicle protein beta-COP by promoting its interaction with the deubiquitinase USP10, which accelerates its proteasomal degradation.

Sarayu Ramakrishna, Laura Ryan, Sung-Min Son et al. · 0 citations
Aug 2026

Artemisinin Attenuates Aβ1-42 Aggregation via the CaMK IV/PKA-CREB-Ace-H4 Cascade in Neuronal Cultures and 3xTg-AD Models.

Alzheimer's disease (AD), a progressive neurodegenerative disease with a rising global prevalence, is characterized by amyloid-β (Aβ) aggregation, tau hyperphosphorylation, inflammation, oxidative damage, and neuronal apoptosis. Studies have increasingly recognized epigenetic modifications as key regulators in the deve...

Yi-Tian Chen, Li-Jun Ge, Philip Lazarovici et al. · 0 citations
Review Open access Oct 2026

Acetylation–ubiquitination crosstalk in NLRP3–gasdermin pyroptosis: a substrate-state framework with relevance to ulcerative colitis

Acetylation and ubiquitination regulate inflammatory cell death, but evidence that they act together in ulcerative colitis (UC) remains limited. This review examines their interactions in nucleotide-binding oligomerisation domain-, leucine-rich repeat- and pyrin domain-containing protein 3 (NLRP3) and gasdermin D (GSDM...

Yuan-Yang Zhao, Xiao-Jie Zhu, En-Hui Lu et al. · 0 citations
Review Nov 2026

Ubiquitin-Proteasome Dysfunction in Huntington's Disease and Its Mechanistic Insights and Druggable Targets Across the Proteostasis Network

Huntington's disease (HD) offers a particularly instructive, if sobering, window into what happens when a cell's protein-clearance machinery is asked to do more than it can bear. Background: the ubiquitin-proteasome system (UPS) is the principal route by which short-lived and misfolded proteins are removed from eukaryo...

Unknown authors · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.